Literature DB >> 24370836

Effect of coadministration of neuronal growth factors on neuroglial differentiation of bone marrow-derived stem cells in the ischemic retina.

Nitza Goldenberg-Cohen1, Bat-Chen R Avraham-Lubin, Tamilla Sadikov, Nadir Askenasy.   

Abstract

PURPOSE: Brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) have limited and transient supportive effects on retinal recovery from ischemia. The aim of this study was to investigate their effect on engrafted adult bone marrow-derived stem cells in a rodent model of anterior ischemic optic neuropathy (rAION).
METHODS: Small cells were isolated from the bone marrow of green fluorescent protein expressing mice by counterflow centrifugal elutriation, depleted of cells expressing lineage markers, and grafted in conjunction with growth factors into the vitreous body of mice with unilateral rAION. Progenitors were mobilized with granulocyte macrophage colony-stimulating factor (GM-CSF) or stem cell factor (SCF). The contralateral eye served as a control.
RESULTS: At 4 weeks, the quantitative incorporation of donor cells in the injured retina was increased by BDNF (P < 0.01 versus control) and decreased by CNTF (P < 0.01 versus control), with no notable difference at 24 weeks. Both growth factors improved the short-term and long-term qualitative engraftment of cells adopting neural phenotypes in the retinal ganglion cell (RGC) layer and astrocyte phenotypes in the anterior vasculature. The RGC-engrafted cells formed extensions toward the inner nuclear layer. In the presence of growth factors, donor cells migrated to the optic nerve and contributed to repair by gliosis. Mobilization with GM-CSF restricted cell fate to microglia, whereas SCF was associated with limited neuroglial differentiation.
CONCLUSIONS: Both BDNF and CNTF enhance engraftment and neuroglial differentiation of adult bone marrow stem cells in injured retina, with BDNF having an early quantitative and qualitative advantage over CNTF. Mobilization with differentiation factors restricts cell fate in the injured retina.

Entities:  

Keywords:  bone marrow–derived stem cells (BMSC); cell migration; mouse model; neuronal growth factors; stem cell differentiation

Mesh:

Substances:

Year:  2014        PMID: 24370836     DOI: 10.1167/iovs.13-12223

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Comparison of three fluorescence labeling and tracking methods of endothelial progenitor cells in laser-injured retina.

Authors:  Hui Shi; Xin-Rui Wang; Ming-Chao Bi; Wei Yang; Dan Wang; Hai-Le Liu; Ling-Ling Liang; Xiao-Hong Li; Qian Hao; Zhi-Hua Cui; E Song
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

Review 2.  Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.

Authors:  Igor Khalin; Renad Alyautdin; Ganna Kocherga; Muhamad Abu Bakar
Journal:  Int J Nanomedicine       Date:  2015-04-30

Review 3.  A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia.

Authors:  Punam P Parikh; Zhao-Jun Liu; Omaida C Velazquez
Journal:  Stem Cells Int       Date:  2017-11-20       Impact factor: 5.443

4.  Multimodal Delivery of Isogenic Mesenchymal Stem Cells Yields Synergistic Protection from Retinal Degeneration and Vision Loss.

Authors:  Benjamin Bakondi; Sergey Girman; Bin Lu; Shaomei Wang
Journal:  Stem Cells Transl Med       Date:  2016-09-09       Impact factor: 6.940

5.  Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy.

Authors:  Wei Zhang; Yuexin Wang; Jiahui Kong; Meng Dong; Hongtao Duan; Song Chen
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 6.  The promise of stem cell-based therapeutics in ophthalmology.

Authors:  Israel Aharony; Shalom Michowiz; Nitza Goldenberg-Cohen
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

7.  Transcriptomic Analysis Reveals That Granulocyte Colony-Stimulating Factor Trigger a Novel Signaling Pathway (TAF9-P53-TRIAP1-CASP3) to Protect Retinal Ganglion Cells after Ischemic Optic Neuropathy.

Authors:  Rong-Kung Tsai; Keh-Liang Lin; Chin-Te Huang; Yao-Tseng Wen
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

Review 8.  Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges.

Authors:  Rosa M Coco-Martin; Salvador Pastor-Idoate; Jose Carlos Pastor
Journal:  Pharmaceutics       Date:  2021-06-11       Impact factor: 6.321

Review 9.  Cell Therapy in Patients with Critical Limb Ischemia.

Authors:  Rita Compagna; Bruno Amato; Salvatore Massa; Maurizio Amato; Raffaele Grande; Lucia Butrico; Stefano de Franciscis; Raffaele Serra
Journal:  Stem Cells Int       Date:  2015-08-02       Impact factor: 5.443

10.  Cell Based Therapeutic Approach in Vascular Surgery: Application and Review.

Authors:  Aldo Rocca; Domenico Tafuri; Marianna Paccone; Antonio Giuliani; Anna Ginevra Immacolata Zamboli; Giuseppe Surfaro; Andrea Paccone; Rita Compagna; Maurizo Amato; Raffaele Serra; Bruno Amato
Journal:  Open Med (Wars)       Date:  2017-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.